Cas No.: | 1333990-84-3 |
Synonyms: | ELND 0006,ELND-0006,ELND0006 |
SMILES: | O=S(N1[C@H](C2CC2)C3=C(NN=C3)C4=C1C=C(F)C(F)=C4)(C5=CC=C(C(F)(F)F)C=C5)=O |
Formula: | C20H14F5N3O2S |
M.Wt: | 455.4 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | ELND006 is a novel gamma secretase inhibitor previously under investigation for the oral treatment of Alzheimer's disease. ELND006 shows poor solubility and has moderate to high permeability. The in vivo performance of the ELND006 nanosuspension was tested in fed and fasted beagle dogs and compared with a gelatin capsule containing reference API. . For the detailed information of ELND0006, the solubility of ELND0006 in water, the solubility of ELND0006 in DMSO, the solubility of ELND0006 in PBS buffer, the animal experiment (test) of ELND0006, the cell expriment (test) of ELND0006, the in vivo, in vitro and clinical trial test of ELND0006, the EC50, IC50,and affinity,of ELND0006, Please contact DC Chemicals. |